Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Clin Pharmacol Ther. 2017 Apr 4;102(3):397–404. doi: 10.1002/cpt.668

Figure 3. Dosing recommendations for Warfarin dosing based on genotype for pediatric patients.

Figure 3

aData strongest for European ancestry populations and consistent in most Japanese studies.

b“Dose clinically” means to dose without genetic information, which may include use of a clinical dosing algorithm or standard dose approach

cValidated published pediatric pharmacogenetic algorithms include Hamberg et al.(42) and Biss et al.(41)

dNo studies in children included CYP2C9*5, *6, *8, or *11 genotyping.